Hope and skepticism abound around Biogen and Eisai Alzheimer’s trial
Sunday, July 29, 2018 - 08:40
in Health & Medicine
An antibody called BAN2401 cleared amyloid-β proteins and slowed cognitive decline in people with mild Alzheimer’s disease